Fortrea Holdings FTRE
$18.55 −$1.60 (-7.94%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.55 0.00%
Open$19.89
Prev close$20.15
Day range$18.30 – $20.52
Volume1.54M
Market cap$1.79B
P/E (TTM)–
Dividend yield–
FTRE Stock News
Headlines matching Fortrea Holdings or the FTRE ticker, most recent first.
- UBS Initiates Fortrea Holdings(FTRE.US) With Hold Rating, Announces Target Price $22
- Analysts' Top Healthcare Picks: Revolution Medicines (RVMD), Fortrea Holdings Inc. (FTRE)
- Barclays Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $22
- Truist Financial Maintains Fortrea Holdings(FTRE.US) With Buy Rating
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Fortrea Holdings Inc. (FTRE), Medtronic (MDT) and Immunic (IMUX)
- William Blair Maintains Fortrea Holdings(FTRE.US) With Hold Rating
- Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)
- TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Maintains Target Price $23
- TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Raises Target Price to $23 Positive
- Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE) Positive
- Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)
- A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $22 to $26
- Citi Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Announces Target Price $22
- Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE)
No comments yet — be the first to weigh in on FTRE.
Sign in to join the discussion.